

Molecular virologist with expertise in RNA virus biology, viral replication dynamics, and molecular diagnostic development. My research focuses on understanding viral-host interactions and identifying biomarkers of active infection to improve the detection of emerging viral pathogens. I have developed CRISPR-Cas13a-based diagnostic approaches targeting the complementary negative RNA strand (antigenome) of coronaviruses to distinguish actively replicating virus from residual genomic RNA. My work integrates experimental virology, molecular diagnostics, and public health perspectives to advance tools for the surveillance and response to emerging infectious diseases.
Secretary, Genomics Forum, American Public Health Association (APHA), 2026-Present
Member
Preprints
Manuscripts in Preparation